Evidence map›Paper›PMID 39116273›Full record

ArticleJournal of medicinal chemistry2024

Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities.

Rahul Deb, Marcelo D T Torres, Miroslav Boudný, Markéta Koběrská, Floriana Cappiello, Miroslav Popper, Kateřina Dvořáková Bendová, Martina Drabinová, Adelheid Hanáčková, Katy Jeannot and 6 more

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Mechanism-Driven Screening of Membrane-Targeting and Pore-Forming Antimicrobial Peptides.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rahul DebCEITEC - Central European Institute of Technology, Masaryk University, Brno 625 00, Czech Republic.ORCID 0000-0002-2733-7012
Marcelo D T TorresMachine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Miroslav BoudnýCEITEC - Central European Institute of Technology, Masaryk University, Brno 625 00, Czech Republic.
Markéta KoběrskáInstitute of Microbiology, Czech Academy of Sciences, BIOCEV, Vestec 252 50, Czech Republic.ORCID 0000-0002-9787-4227
Floriana CappielloDepartment of Biochemical Sciences, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome 00185, Italy.
Miroslav PopperInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc 779 00, Czech Republic.
Kateřina Dvořáková BendováInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc 779 00, Czech Republic.
Martina DrabinováCEITEC - Central European Institute of Technology, Masaryk University, Brno 625 00, Czech Republic.
Adelheid HanáčkováCEITEC - Central European Institute of Technology, Masaryk University, Brno 625 00, Czech Republic.
Katy JeannotUniversity of Franche-Comté, CNRS, Chrono-environment, Besançon 25030, France.
Miloš PetříkInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc 779 00, Czech Republic.ORCID 0000-0003-1334-5916
Maria Luisa MangoniDepartment of Biochemical Sciences, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome 00185, Italy.ORCID 0000-0002-5991-5868
Gabriela Balíková NovotnáInstitute of Microbiology, Czech Academy of Sciences, BIOCEV, Vestec 252 50, Czech Republic.
Marek MrázCEITEC - Central European Institute of Technology, Masaryk University, Brno 625 00, Czech Republic.
Cesar de la Fuente-NunezMachine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Robert VáchaCEITEC - Central European Institute of Technology, Masaryk University, Brno 625 00, Czech Republic.ORCID 0000-0001-7610-658X

Funding

Combining chemical and computational tools for predictive models of microbiome communitiesR35GM138201 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DE LA FUENTE, CESAR · 2020 to 2024
$1.8M
NIGMS NIH HHS R35 GM138201
6 · The paper itself

Abstract

Peptides that form transmembrane barrel-stave pores are potential alternative therapeutics for bacterial infections and cancer. However, their optimization for clinical translation is hampered by a lack of sequence-function understanding. Recently, we have

Indexed as

Antineoplastic AgentsDrug DesignAcinetobacter baumanniiAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesCell Line, TumorHumansMiceMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesAntineoplastic Agents

Identifiers

PMID39116273
PMCPMC11345766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.